| Dec'19 | Dec'18 | Dec'17 | Dec'16 | |||
|---|---|---|---|---|---|---|
Cash flows from operating activities | ||||||
Net loss | ||||||
-217,751 | -52,983 | -67,682 | -70,911 | |||
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities | ||||||
Depreciation | ||||||
50,544 | 54,300 | 53,400 | 55,260 | |||
Amortization of intangibles | ||||||
18,367 | 9,558 | 8,799 | 9,083 | |||
Amortization of deferred financing costs | ||||||
2,984 | 2,966 | 1,615 | 2,355 | |||
Provision for (recovery of) doubtful accounts | ||||||
849 | -268 | 176 | 0 | |||
Benefit for deferred income taxes | ||||||
-4,327 | 898 | -5,815 | -12,159 | |||
Provision for inventory obsolescence | ||||||
5,148 | 844 | 1,359 | 287 | |||
Impairment of Intangible Assets (Excluding Goodwill) | ||||||
114,804 | 19,065 | 3,800 | 0 | |||
Stock-based compensation expense | ||||||
14,057 | 13,221 | 7,568 | 5,711 | |||
Impairment of property and equipment | ||||||
66,200 | 45,694 | 0 | 0 | |||
Impairment of goodwill | ||||||
20,273 | 12,986 | 31,530 | 12,207 | |||
Gain on sale of property and equipment | ||||||
538 | 1,731 | -4,688 | -3,320 | |||
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability | ||||||
-21,187 | 3,262 | 415 | 1,735 | |||
Gain (Loss) on Disposition of Business | ||||||
-15,896 | 0 | 0 | - | |||
Loss on equity method investment | ||||||
0 | -347 | -368 | 0 | |||
Changes in operating assets and liabilities, net of effects from acquisitions | ||||||
Accounts receivable, net | ||||||
-41,852 | 24,972 | 52,180 | -2,073 | |||
Inventories, net | ||||||
-22,545 | 15,041 | 8,212 | 558 | |||
Prepaid expenses and other current assets | ||||||
-2,395 | 5,722 | -1,472 | 3,172 | |||
Accounts payable and accrued expenses | ||||||
-27,901 | 27,156 | 12,530 | -2,396 | |||
Income taxes receivable/payable | ||||||
-294 | -255 | 15,158 | -5,848 | |||
Other assets and liabilities | ||||||
2,611 | -295 | 3,340 | 277 | |||
Net cash provided by operating activities | ||||||
101,305 | 89,577 | 5,671 | -3,290 | |||
Cash flows from investing activities | ||||||
Acquisitions, net of cash acquired | ||||||
-1,020 | 349,986 | 0 | 0 | |||
Proceeds from Divestiture of Interest in Consolidated Subsidiaries | ||||||
16,914 | 0 | 0 | - | |||
Proceeds from sales of property and equipment | ||||||
3,702 | 2,183 | 1,452 | 2,918 | |||
Proceeds from property and equipment casualty losses | ||||||
1,576 | 1,743 | 300 | 262 | |||
Proceeds from notes receivable payments | ||||||
7,626 | 2,941 | 0 | 1,774 | |||
Equity method investment | ||||||
0 | 0 | 1,000 | 0 | |||
Purchases of property and equipment | ||||||
64,959 | 46,646 | 45,216 | 9,130 | |||
Net cash provided by (used in) investing activities | ||||||
-34,121 | -389,765 | -44,464 | -4,176 | |||
Proceeds from revolving credit facilities | ||||||
10,000 | 35,000 | 56,481 | 75,136 | |||
Payments on 2018 ABL Credit Facility | ||||||
45,000 | 96,182 | 38,287 | 61,956 | |||
Proceeds from Senior Notes | ||||||
0 | 400,000 | 0 | 0 | |||
Payments on term loans | ||||||
0 | 270,975 | 22,475 | 19,725 | |||
Proceeds from term loan | ||||||
0 | 125,000 | 0 | 0 | |||
Proceeds from notes payable—insurance premium financing | ||||||
- | - | - | 1,127 | |||
Payments on notes payable – insurance premium financing | ||||||
0 | 0 | 272 | 855 | |||
Payments on capital leases | ||||||
903 | 128 | 0 | 0 | |||
Payments of contingent liability | ||||||
374 | 3,445 | 1,325 | 297 | |||
Proceeds from issuance of common stock in IPO, net of offering costs | ||||||
0 | 171,450 | 0 | 0 | |||
Proceeds from other issuances of common stock | ||||||
0 | 300 | 61,374 | 500 | |||
Proceeds from exercise of stock options | ||||||
15 | 2,905 | 0 | 0 | |||
Vesting of restricted stock | ||||||
1,643 | 927 | 0 | 0 | |||
Distribution to non-accredited investors | ||||||
0 | 0 | 2,438 | 0 | |||
Cost of debt issuance | ||||||
0 | 16,307 | 716 | 1,245 | |||
Net cash used in financing activities | ||||||
-37,905 | 346,691 | 52,342 | -7,315 | |||
Impact of foreign currency exchange on cash | ||||||
95 | -401 | -110 | -22 | |||
Net decrease in cash and cash equivalents | ||||||
29,374 | 46,102 | 13,439 | -14,803 | |||
Supplemental disclosures of cash flow information: | ||||||
Cash paid for interest | ||||||
37,376 | 5,981 | 14,987 | 12,442 | |||
Cash paid (refunded) for income taxes | ||||||
517 | 1,697 | -14,344 | -8,716 | |||
Non-cash investing and financing activities: | ||||||
Issuance of common stock related to business acquisitions | ||||||
0 | 177,847 | 547 | 0 | |||
Contingent liability related to business acquisitions | ||||||
0 | 23,982 | 0 | 0 | |||
Capital expenditures in accounts payable and accrued expenses | ||||||
10 | 4,476 | 1,675 | 1,540 | |||
Property and equipment obtained by capital lease | ||||||
1,621 | 3,123 | 0 | 0 | |||
Receivable from property and equipment sale (including insurance) | ||||||
5,949 | 1,199 | 0 | 0 | |||